Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
NCT02852564
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Bladder Cancer
Interventions
DRUG:
Ethacrynic Acid
Sponsor
Eugene Lee, MD
Collaborators
[object Object]